Glaukos Corporation (GKOS) vs Penumbra, Inc. (PEN)
- Glaukos Corporation GKOS 225.16 +2.35%
- Penumbra, Inc. PEN 319.79 −0.41%
Glaukos Corporation and Penumbra, Inc. are both Medical Devices companies. Glaukos Corporation and Penumbra, Inc. are of similar size ($13.0B and $12.7B). Glaukos Corporation has negative trailing earnings, so its P/E is not meaningful; Penumbra, Inc. trades at 80.3×. Glaukos Corporation grew revenue faster over the last twelve months: 46.9% against 17.0%. Penumbra, Inc. has the higher net margin (10.1% vs −24.6%) and the higher return on invested capital (12.7% vs −24.6%). Across the 19 metrics below, Penumbra, Inc. leads on 17 and Glaukos Corporation on 2.
Valuation
Profitability
| Metric | GKOS | PEN | Medical Devices median |
|---|---|---|---|
| Gross margin | 81.13% | 67.98% | 57.76% |
| Operating margin | (25.52%) | 12.13% | (15.07%) |
| Net margin | (24.60%) | 10.06% | (14.45%) |
| Free cash flow margin | 5.22% | 12.84% | (3.88%) |
| Return on equity | (22.84%) | 10.67% | (10.35%) |
| Return on assets | (17.16%) | 8.33% | (17.26%) |
| Return on invested capital | (24.60%) | 12.73% | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack